EyePoint, Inc. (FRA:PV3B)

Germany · Delayed Price · Currency is EUR

12.02

+0.10 (0.80%)

Last updated: Feb 20, 2026, 3:25 PM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Developing and Commercializing Innovative Ophthalmic Products	43.27M	46.02M	41.40M	36.94M	34.44M
Developing and Commercializing Innovative Ophthalmic Products Growth	-5.97%	11.14%	12.09%	7.27%	69.10%
Total	43.27M	46.02M	41.40M	36.94M	34.44M
Total Growth	-5.97%	11.14%	12.09%	7.27%	69.10%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States (U.S.)	42.05M	45.27M	40.48M	35.99M	22.62M
United States (U.S.) Growth	-7.12%	11.83%	12.48%	59.07%	18.18%
China	1.12M	648.00K	823.00K	851.00K	11.71M
China Growth	73.46%	-21.26%	-3.29%	-92.73%	944.87%
United Kingdom (U.K.)	100.00K	100.00K	100.00K	100.00K	100.00K
United Kingdom (U.K.) Growth	0%	0%	0%	0%	0%
Total	43.27M	46.02M	41.40M	36.94M	34.44M
Total Growth	-5.97%	11.14%	12.09%	7.27%	69.10%

Source: S&P Global Market Intelligence.